Characterization of a nonribosomal peptide antibiotic solid dispersion formulation by process analytical technologies sensors

Journal of Pharmaceutical Sciences

Volumn 102, Issue 12, 2013, Pages 4337-4346

  Rahman, Ziyaur ^a   Siddiqui, Akhtar ^a   Khan, Mansoor A ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

chemometrics; crystal defects; dissolution; fourier infrared spectroscopy; multivariate analysis; partial least square analysis; powder X ray diffration; principle component analysis; solid dispersion

Indexed keywords

DRUG CARRIER; MACROGOL 6000; VANCOMYCIN;

ARTICLE; CRYSTAL STRUCTURE; DISPERSION; DRUG ANALYSIS; DRUG FORMULATION; DRUG SOLUBILITY; HEAT; NEAR INFRARED SPECTROSCOPY; PARTIAL LEAST SQUARES REGRESSION; PHYSICAL CHEMISTRY; PRINCIPAL COMPONENT ANALYSIS; PROCESS ANALYTICAL TECHNOLOGY SENSOR; SENSOR; X RAY POWDER DIFFRACTION;

CHEMOMETRICS; CRYSTAL DEFECTS; DISSOLUTION; FOURIER INFRARED SPECTROSCOPY; MULTIVARIATE ANALYSIS; PARTIAL LEAST SQUARE ANALYSIS; POWDER X-RAY DIFFRATION; PRINCIPLE COMPONENT ANALYSIS; SOLID DISPERSION;

ANTI-BACTERIAL AGENTS; CRYSTALLIZATION; EXCIPIENTS; LEAST-SQUARES ANALYSIS; POLYETHYLENE GLYCOLS; POWDER DIFFRACTION; PRINCIPAL COMPONENT ANALYSIS; SOLUBILITY; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; VANCOMYCIN; X-RAY DIFFRACTION;

EID: 84888206040     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.23740     Document Type: Article

References (45)

1. US FDA/CDER. 2004. Guidance for industry. PAT-A framework for innovative pharmaceutical development, manufacturing, and quality assurance. US FDA, Rockville, MD, USA.
2. Zidan AS, Habib MJ, Khan MA,. 2008. Process analytical technology: Nondestructive evaluation of cyclosporine A and phospholipid solid dispersions by near infrared spectroscopy and imaging. J Pharm Sci 97: 3388-3399.
3. Coates JP,. 2005. Process analytical technology;, Bakeev KA, Ed. Oxford: Blackwell Publishing, p 91.
4. Lai CK, Cooney CL,. 2003. Application of a fluorescence sensor for miniscale on-line monitoring of powder mixing kinetics. J Pharm Sci 93: 60-70.
5. Baughman E., 2005. Process analytical technology;, Bakeev KA, Ed. Oxford: Blackwell Publishing, p 1.
6. Lewis EN, Schoppelrei J, Lee E,. 2004. Molecular spectroscopy workbench near-infrared chemical imaging and the PAT initiative. Spectroscopy 19: 26-36.
7. Bodson C, Rozet E, Ziemons E, Evrard B, Hubert Ph, Delattre L,. 2007. Validation of manufacturing process of diltiazem HCl tablets by NIR spectrophotometry (NIRS). J Pharm Biomed Anal 45: 356-361.
8. Phadnis NV, Cavatur RK, Suryanarayanan R,. 1997. Identification of drugs in pharmaceutical dosage forms by X-ray powder diffractometry. J Pharm Biomed Anal 15: 929-943.
9. Davey RJ, Liu W, Quayle MJ, Tiddy GJT,. 2002. In situ monitoring of crystallization processes using synchrotron X-ray diffraction: The search for structural precursors. Cryst Growth Design 2: 269-272.
10. Dharmayat S, De Anda JC, Hammond RB, Lai X, Roberts KJ, Wang XZ,. 2006. Polymorphic transformation of l -glutamic acid monitored using combined on-line video microscopy and X-ray diffraction. J Cryst Growth 294: 35-40.
11. Davis TD, Morris KR, Huang H, Peck GE, Stowell JG, Eisenhauer BJ, Hilden JL, Gibson D, Byrn SR,. 2003. In situ monitoring of wet granulation using online X-ray powder diffraction. Pharm Res 20: 1851-1857.
12. Dash AK, Khin-Khin A, Suryanarayanan R,. 2002. X-ray powder diffractometric method for quantitation of crystalline drug in microparticulate systems. I. Microspheres. J Pharm Sci 91: 983-990.
13. de Villiers MM, Wurster DE, Van der Watt JG, Ketkar A,. 1998. X-ray powder diffraction determination of the relative amount of crystalline acetaminophen in solid dispersions with polyvinylpyrrolidone. Int J Pharm 163: 219-224.
14. Uvarov V, Popov I,. 2007. Metrological characterization of X-ray diffraction methods for determination of crystallite size in nano-scale materials. Mater Charact 58: 883-891.
15. Stephenson GA, Young R,. 2001. Potential applications of Rietveld analysis in the pharmaceutical industry. Am Pharm Rev 4: 46-51.
16. Chen X, Bates S, Morris KR,. 2001. Quantifying amorphous content of lactose using parallel beam X-ray powder diffraction and whole pattern fitting. J Pharm Biomed Anal 26: 63-72.
17. Mateos AG., 1992. Quantitative XRD analysis by partial least squares application in a commercial product. Advances in X-ray analysis;, Barrett CS, Gilfrich JV, Huang TC, Jenkins R, McCarthy GJ, Predecki PK, Ryon R, Smith DK, Ed. New York: Plenum Publishing Corporation Vol 35A, pp 117-126.
18. Nagarajan R., 1991. Antibacterial activities and modes of action of vancomycin and related glycopeptides. Antimicrob Agents Chemother 35: 605-609.
19. Hammet-Stabler CA, Johns T,. 1998. Laboratory guidelines for monitoring of antimicrobial drugs. Clin Chem 44: 1129-1140.
20. Reynolds JEF., 1996. Martindale The Extra Pharmacopoeia. London: The Pharmaceutical Press, pp 295-297.
21. Khan MA, Karnachi AA, Agarwal V, Vaithiyalingam SV, Nazzal S, Reddy IK,. 2000. Stability characterization of controlled release coprecipitates and solid dispersions. J Control Release 63: 1-6.
22. Serajuddin ATM., 1999. Solid dispersion of poorly water soluble drugs: Early promises, subsequent problems, and reecent breakthroughs. J Pharm Sci 88: 1058-1066.
23. Okonogi S, Puttipipatkhachorn S,. 2006. Dissolution improvement of high drug-loaded solid dispersion. AAPS PharmSciTech 7 (2):Article 52.
24. Craig DQM., 1990. Polyethyelene glycols and drug release. Drug Dev Ind Pharm 16: 2501-2526.
25. Vancocin hcl (vancomycin hydrochloride) capsule. ViroPharma Incorporated. Accessed on March 02, 2013, at: http://dailymed.nlm.nih.gov/dailymed/archives/ fdaDrugInfo.cfm?archiveid=7608.
26. Mahato RI,. 2013. Dosage forms and drug delivery systems. In APhA'S complete review for pharmacy;, Gourley DR, Eoff III, JC, Eds. 10th ed., pp 37-63.
27. International Conference of Harmonization. 2005. Validation of analytical procedures, Q2(R1).
28. International Conference of Harmonization. 2003. Stability testing of new drug substances and products, Q1A(R2).
29. Lippold BC, Ohm A,. Correlation between wettability and dissolution rate of pharmaceutical powders. Int J Pharm 28: 67-74.
30. Zerrouk N, Chemtob C, Arnaud P, Toscani S, Dugue J,. 2001. In vitro and in vivo evaluation of carbamazepine-PEG 6000 solid dispersions. Int J Pharma 225: 49-62.
31. United States Pharmacopeia 32-National Formulary 27. 2009. Vancomycin Monogram. Rockville, Maryland: USP, p 3846.
32. Khan KA,. 1995. The concept of dissolution efficiency. J Pharm Pharmacol 27: 48-49.
33. Damian F, Blaton N, Kinget R, Van den Mooter G,. 2002. Physical stability of solid dispersions of the antiviral agent UC-781 with PEG 6000, Gelucire† 44/14 and PVP K30. Int J Pharm 244: 87-98.
34. Kedzierewicz F, Villieras F, Zinutti C, Hoffman M, Maincent P,. 1995. A 3 year stability study of tolbutamide solid dispersions and β-cyclodextrin complex. Int J Pharm 117: 247-251.
35. Weuts I, Kempen D, Decorte A, Verreck G, Peeters J, Brewster M, Van den Mooter G,. 2005. Physical stability of the amorphous state of loperamide and two fragment molecules in solid dispersions with the polymers PVP-K30 and PVP-VA64. Eur J Pharm Sci 25: 313-320.
36. Newman A, Knipp G, Zografi G,. 2012. Assessing the performance of amorphous solid dispersions. J Pharm Sci 101: 1355-1377.
37. Nassab PR, Rajko R, Szabo-Revesz P,. 2006. Physicochemical characterization of meloxicam-mannitol binary systems. J Pharm Biomed Anal 41: 1191-1197.
38. Shahroodi AB, Nassab PR, Révész PS,. 2008. Preparation of a solid dispersion by a dropping method to improve the rate of dissolution of meloxicam. Drug Dev Ind Pharm 34: 781-788.
39. Heigl N, Petter CH, Lieb M, Bonn GK, Huck CW,. 2009. Near-infrared reflection spectroscopy and partial least squares regression for determining the total carbon coverage of silica packings for liquid chromatography. Vibr Spectrosc 49: 155-161.
40. Smith RC, Baker KS,. 1981. Optical properties of clearest natural waters (200-800nm). Appl Opt 20: 177-184.
41. Suda M, Takayama K, Otsuka M,. 2008. An accurate quantitative analysis of polymorphic content by chemometric X-ray powder diffraction. Anal Sci 24: 451-457.
42. Geladi P, MacDougall D, Martens H,. 1985. Linearization and scatter-correction for near-infrared reflectance spectra of meat. Appl Spectrosc 39:: 491-500.
43. Tahboub YR, Pardue HL,. 1985. Evaluation of multiwavelength first- and second-derivative spectra for the quantitation of mixtures of polynuclear aromatic hydrocarbons. Anal Chem 57: 38-41.
44. Braga JWB, Poppi RJ,. 2004. Validation of models of multivariate calibration: An application in the determination of polymorphic purity of carbamazepine by near infrared spectroscopy. Quim Nova 27: 1004-1011.
45. Otsuka M., 2004. Comparative particle size determination of phenacetin bulk powder by using kubelka-Munk theory and principal component regression analysis based on near infrared spectroscopy. Powder Technol 141: 244-250.